ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 164 filers reported holding ANIKA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 3.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $271,402 | -37.1% | 14,568 | -12.3% | 0.00% | – |
| Q2 2023 | $431,372 | +9.3% | 16,604 | +20.8% | 0.00% | – |
| Q1 2023 | $394,671 | +24.0% | 13,742 | +27.8% | 0.00% | – |
| Q4 2022 | $318,171 | -30.8% | 10,749 | -44.4% | 0.00% | -100.0% |
| Q3 2022 | $460,000 | +7.0% | 19,331 | +0.3% | 0.00% | – |
| Q2 2022 | $430,000 | -15.2% | 19,265 | -4.5% | 0.00% | – |
| Q1 2022 | $507,000 | -19.3% | 20,174 | +15.1% | 0.00% | – |
| Q4 2021 | $628,000 | -19.5% | 17,533 | -4.3% | 0.00% | – |
| Q3 2021 | $780,000 | -11.4% | 18,328 | -9.8% | 0.00% | – |
| Q2 2021 | $880,000 | +11.8% | 20,313 | +5.2% | 0.00% | – |
| Q1 2021 | $787,000 | -34.4% | 19,300 | -27.1% | 0.00% | -100.0% |
| Q4 2020 | $1,200,000 | +27.1% | 26,492 | -0.8% | 0.00% | 0.0% |
| Q3 2020 | $944,000 | -23.4% | 26,703 | -18.2% | 0.00% | 0.0% |
| Q2 2020 | $1,232,000 | +69.9% | 32,650 | +30.1% | 0.00% | 0.0% |
| Q1 2020 | $725,000 | -46.3% | 25,096 | -3.7% | 0.00% | 0.0% |
| Q4 2019 | $1,351,000 | +97.2% | 26,058 | +109.2% | 0.00% | 0.0% |
| Q3 2019 | $685,000 | +86.6% | 12,454 | +37.9% | 0.00% | – |
| Q2 2019 | $367,000 | -10.0% | 9,029 | -33.1% | 0.00% | – |
| Q1 2019 | $408,000 | -6.0% | 13,490 | +4.3% | 0.00% | – |
| Q4 2018 | $434,000 | -5.4% | 12,928 | +19.0% | 0.00% | – |
| Q3 2018 | $459,000 | -7.5% | 10,868 | -29.9% | 0.00% | – |
| Q2 2018 | $496,000 | -36.7% | 15,507 | -1.6% | 0.00% | -100.0% |
| Q1 2018 | $783,000 | +16.7% | 15,765 | +26.7% | 0.00% | 0.0% |
| Q4 2017 | $671,000 | -35.4% | 12,444 | -30.6% | 0.00% | 0.0% |
| Q3 2017 | $1,039,000 | +216.8% | 17,930 | +170.3% | 0.00% | – |
| Q2 2017 | $328,000 | -50.3% | 6,634 | -56.4% | 0.00% | -100.0% |
| Q1 2017 | $660,000 | -36.7% | 15,207 | -28.7% | 0.00% | 0.0% |
| Q4 2016 | $1,043,000 | +39.4% | 21,315 | +36.5% | 0.00% | 0.0% |
| Q3 2016 | $748,000 | -54.3% | 15,620 | -48.8% | 0.00% | -50.0% |
| Q2 2016 | $1,638,000 | -19.9% | 30,536 | -33.2% | 0.00% | 0.0% |
| Q1 2016 | $2,044,000 | +124.1% | 45,704 | +91.2% | 0.00% | +100.0% |
| Q4 2015 | $912,000 | +100.9% | 23,900 | +67.9% | 0.00% | 0.0% |
| Q3 2015 | $454,000 | -5.4% | 14,238 | -1.9% | 0.00% | – |
| Q2 2015 | $480,000 | -1.2% | 14,514 | +23.0% | 0.00% | – |
| Q1 2015 | $486,000 | -27.7% | 11,798 | -28.5% | 0.00% | -100.0% |
| Q4 2014 | $672,000 | -22.8% | 16,507 | -30.5% | 0.00% | 0.0% |
| Q3 2014 | $870,000 | -49.7% | 23,749 | -36.5% | 0.00% | 0.0% |
| Q2 2014 | $1,731,000 | -6.3% | 37,404 | -16.8% | 0.00% | -50.0% |
| Q1 2014 | $1,847,000 | +145.0% | 44,942 | +127.4% | 0.00% | +100.0% |
| Q4 2013 | $754,000 | +96.4% | 19,760 | +23.2% | 0.00% | – |
| Q3 2013 | $384,000 | +54.2% | 16,044 | +9.4% | 0.00% | – |
| Q2 2013 | $249,000 | – | 14,672 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Caligan Partners LP | 591,675 | $17,513,580 | 14.58% |
| Trigran Investments, Inc. | 1,564,541 | $46,310,413 | 4.64% |
| DIKER MANAGEMENT LLC | 22,458 | $664,757 | 0.77% |
| Virtus Fund Advisers, LLC | 3,490 | $103,304 | 0.74% |
| Portolan Capital Management | 207,900 | $6,153,840 | 0.61% |
| Virtus Investment Advisers, Inc. | 16,086 | $476,146 | 0.32% |
| Ranger Investment Management | 140,205 | $4,150,068 | 0.31% |
| BOOTHBAY FUND MANAGEMENT, LLC | 367,510 | $10,878,296 | 0.25% |
| Riverwater Partners LLC | 9,778 | $289,429 | 0.25% |
| Legato Capital Management LLC | 7,556 | $223,658 | 0.04% |